We adapted those established in vitro protocols to generate iPSC-derived striatal MSNs from DYT-THAP1 dystonia patients and healthy controls to gain better insights into the pathophysiological processes of this genetic dystonia. The gene discussed is THAP1; the disease is Dystonia.